Integer Holdings Profit Margin 2010-2022 | ITGR

Current and historical gross margin, operating margin and net profit margin for Integer Holdings (ITGR) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Integer Holdings net profit margin as of March 31, 2022 is 6.98%.
Integer Holdings Annual Profit Margins
Integer Holdings Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.383B $1.221B
Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.627B 21.80
Edwards Lifesciences (EW) United States $60.552B 42.53
Alcon (ALC) Switzerland $35.080B 30.59
STERIS (STE) Ireland $21.113B 26.67
Fresenius Medical Care AG KGaA (FMS) Germany $14.716B 13.22
Teleflex (TFX) United States $11.964B 19.12
Globus Medical (GMED) United States $5.873B 29.30
Penumbra (PEN) United States $4.736B 299.29
Glaukos (GKOS) United States $2.256B 0.00
Nevro (NVRO) United States $1.608B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.313B 23.51
Paragon 28 (FNA) United States $1.281B 0.00
Artivion (AORT) United States $0.772B 83.52